Year |
Citation |
Score |
2016 |
Ahmari N, Schmidt JT, Krane GA, Malphurs W, Cunningham BE, Owen JL, Martyniuk CJ, Zubcevic J. Loss of bone marrow adrenergic beta 1 and 2 receptors modifies transcriptional networks, reduces circulating inflammatory factors, and regulates blood pressure. Physiological Genomics. physiolgenomics.0003. PMID 27235450 DOI: 10.1152/physiolgenomics.00039.2016 |
0.305 |
|
2013 |
Owen JL, Mohamadzadeh M. Macrophages and chemokines as mediators of angiogenesis. Frontiers in Physiology. 4: 159. PMID 23847541 DOI: 10.3389/fphys.2013.00159 |
0.563 |
|
2011 |
Owen JL, Criscitiello MF, Libreros S, Garcia-Areas R, Guthrie K, Torroella-Kouri M, Iragavarapu-Charyulu V. Expression of the inflammatory chemokines CCL2, CCL5 and CXCL2 and the receptors CCR1-3 and CXCR2 in T lymphocytes from mammary tumor-bearing mice Cellular Immunology. 270: 172-182. PMID 21621198 DOI: 10.1016/J.Cellimm.2011.05.004 |
0.64 |
|
2008 |
Owen JL, Torroella-Kouri M, Iragavarapu-Charyulu V. Molecular events involved in the increased expression of matrix metalloproteinase-9 by T lymphocytes of mammary tumor-bearing mice. International Journal of Molecular Medicine. 21: 125-34. PMID 18097625 DOI: 10.3892/Ijmm.21.1.125 |
0.676 |
|
2007 |
Owen JL, Torroella-Kouri M, Handel-Fernandez ME, Iragavarapu-Charyulu V. GM-CSF up-regulates the expression of CCL2 by T lymphocytes in mammary tumor-bearing mice. International Journal of Molecular Medicine. 20: 129-36. PMID 17549399 DOI: 10.3892/Ijmm.20.1.129 |
0.729 |
|
2005 |
Torroella-Kouri M, Ma X, Perry G, Ivanova M, Cejas PJ, Owen JL, Iragavarapu-Charyulu V, Lopez DM. Diminished expression of transcription factors nuclear factor kappaB and CCAAT/enhancer binding protein underlies a novel tumor evasion mechanism affecting macrophages of mammary tumor-bearing mice. Cancer Research. 65: 10578-84. PMID 16288051 DOI: 10.1158/0008-5472.Can-05-0365 |
0.68 |
|
2005 |
Owen JL, Lopez DM, Grosso JF, Guthrie KM, Herbert LM, Torroella-Kouri M, Iragavarapu-Charyulu V. The expression of CCL2 by T lymphocytes of mammary tumor bearers: role of tumor-derived factors. Cellular Immunology. 235: 122-35. PMID 16243300 DOI: 10.1016/J.Cellimm.2005.08.032 |
0.71 |
|
2004 |
Owen JL, Iragavarapu-Charyulu V, Lopez DM. T cell-derived matrix metalloproteinase-9 in breast cancer: friend or foe? Breast Disease. 20: 145-53. PMID 15687715 DOI: 10.3233/Bd-2004-20115 |
0.757 |
|
2004 |
Grosso JF, Herbert LM, Owen JL, Lopez DM. MUC1/sec-expressing tumors are rejected in vivo by a T cell-dependent mechanism and secrete high levels of CCL2. Journal of Immunology (Baltimore, Md. : 1950). 173: 1721-30. PMID 15265901 DOI: 10.4049/Jimmunol.173.3.1721 |
0.689 |
|
2003 |
Owen JL, Iragavarapu-Charyulu V, Gunja-Smith Z, Herbert LM, Grosso JF, Lopez DM. Up-regulation of matrix metalloproteinase-9 in T lymphocytes of mammary tumor bearers: role of vascular endothelial growth factor. Journal of Immunology (Baltimore, Md. : 1950). 171: 4340-51. PMID 14530359 DOI: 10.4049/Jimmunol.171.8.4340 |
0.704 |
|
2001 |
Owen J, Gunja-Smith Z, Lopez D. MMP-9 production by T cells from mammary tumor bearers is upregulated by tumor-derived VEGF Breast Cancer Research. 3: 1-1. DOI: 10.1186/Bcr373 |
0.793 |
|
1978 |
Bosma MJ, Bosma GC, Owen JL. Prevention of immunoglobulin production by allotype-dependent T cells. European Journal of Immunology. 8: 562-8. PMID 308880 DOI: 10.1002/eji.1830080805 |
0.383 |
|
Show low-probability matches. |